Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhibition of polyglutamine aggregation in R6/2 HD brain slices-complex dose-response profiles.

D L Smith1, R Portier, B Woodman

  • 1Division of Medical and Molecular Genetics, GKT School of Medicine, London, United Kingdom

Neurobiology of Disease
|December 14, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation.

Brain : a journal of neurology·2002
Same author

Trends in diet, nutritional status, and diet-related noncommunicable diseases in China and India: the economic costs of the nutrition transition.

Nutrition reviews·2002
Same author

Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington's disease (HD) transgenic mice and HD patients.

Human molecular genetics·2001
Same author

Impaired glutamate uptake in the R6 Huntington's disease transgenic mice.

Neurobiology of disease·2001
Same author

Studies towards the next generation of antidepressants. Part 1: Indolylcyclohexylamines as potent serotonin reuptake inhibitors.

Bioorganic & medicinal chemistry letters·2001
Same author

Resistance of human betaB2-crystallin to in vivo modification.

Experimental eye research·2001
Same journal

Loss of immunological control at CD28 superfamily checkpoints links brain and peripheral immunity to depressive-like behaviors in animal models.

Neurobiology of disease·2026
Same journal

Investigating tau-related white matter degeneration in Alzheimer's disease using fixel-based analysis.

Neurobiology of disease·2026
Same journal

Evidence for hippocampal globotriaosylceramide (Gb3) accumulation and spatial memory impairment in a mouse model of Fabry disease.

Neurobiology of disease·2026
Same journal

Leveraging the dominant-negative effect of the kuru-protective G127V prion protein variant as a novel therapeutic strategy.

Neurobiology of disease·2026
Same journal

GDAP1 orchestrates redox signaling at membrane contact sites to preserve axonal integrity in Charcot-Marie-Tooth disease.

Neurobiology of disease·2026
Same journal

Tier-specific location of Lewy body pathology and related neuromelanin levels drive dopaminergic cell vulnerability in pigmented non-human primates.

Neurobiology of disease·2026
See all related articles

Huntington's disease (HD) research shows that a new organotypic slice culture system effectively models polyglutamine (polyQ) aggregate formation. This system validates creatine as an inhibitor of polyQ aggregation, a key target for HD therapies.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Huntington's disease (HD) is a neurodegenerative disorder characterized by CAG/polyglutamine (polyQ) repeat expansion.
  • PolyQ aggregates in neurons are detectable before symptom onset and represent a key therapeutic target.

Purpose of the Study:

  • To develop and validate an organotypic slice culture system for studying polyQ aggregate formation.
  • To assess the efficacy of potential aggregation inhibitors using this novel assay.

Main Methods:

  • Established an organotypic hippocampal slice culture system from R6/2 mice.
  • Monitored polyQ aggregate formation in vitro, comparing it to in vivo progression.
  • Tested the effects of Congo red, chrysamine G, and creatine on aggregate formation.

Related Experiment Videos

Main Results:

  • The slice culture system accurately recapitulates in vivo polyQ aggregate formation.
  • Congo red and chrysamine G demonstrated complex dose-response effects on aggregation.
  • Creatine was found to inhibit polyQ aggregate formation in the slice culture assay.

Conclusions:

  • The organotypic slice culture system is a viable model for studying HD pathogenesis and testing therapeutic interventions.
  • Creatine shows potential as a therapeutic agent by inhibiting polyQ aggregation in a relevant preclinical model.